1. Home
  2. BFLY vs CDNA Comparison

BFLY vs CDNA Comparison

Compare BFLY & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Butterfly Network Inc.

BFLY

Butterfly Network Inc.

SELL

Current Price

$9.07

Market Cap

2.3B

Sector

Health Care

ML Signal

SELL

Logo CareDx Inc.

CDNA

CareDx Inc.

SELL

Current Price

$68.95

Market Cap

2.6B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
BFLY
CDNA
Founded
2011
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Electronics
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.6B
IPO Year
2020
2007

Fundamental Metrics

Financial Performance
Metric
BFLY
CDNA
Price
$9.07
$68.95
Analyst Decision
Strong Buy
Buy
Analyst Count
6
7
Target Price
$11.40
★ $58.83
AVG Volume (30 Days)
★ 5.3M
1.2M
Earning Date
10-30-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 8.82
N/A
EPS
N/A
★ 2.13
Revenue
★ $97,610,000.00
$48,324,000.00
Revenue This Year
$24.74
$30.36
Revenue Next Year
$23.94
$6.23
P/E Ratio
★ N/A
$31.09
Revenue Growth
★ 18.96
18.93
52 Week Low
$1.90
$13.95
52 Week High
$10.05
$67.29

Technical Indicators

Market Signals
Indicator
BFLY
CDNA
Relative Strength Index (RSI) 55.89 82.71
Support Level $3.57 $17.26
Resistance Level $9.79 N/A
Average True Range (ATR) 0.69 3.09
MACD 0.07 1.06
Stochastic Oscillator 68.15 97.48

Price Performance

Historical Comparison
BFLY
CDNA

About BFLY Butterfly Network Inc.

Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. The company operates in one reportable segment, which includes all activities related to the development, manufacture, and sale of the Company's products, software, and other services.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: